Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends extending use of Abraxane to include treatment of pancreatic cancer 22 November 2013Press releaseHumanMedicines European Medicines Agency's Committee on Herbal Medicinal Products elects new chair and vice-chair 20 November 2013NewsHerbalMedicines European Medicines Agency finalises review of medicines concerned by Roche pharmacovigilance inspection 19 November 2013Press releaseCorporateMedicines European Medicines Agency and EUnetHTA agree joint work plan 19 November 2013Press releaseCorporateMedicines Regulatory information - EMA encourages companies to submit quality type-I variations for 2013 by end of November 18 November 2013NewsCorporate European Antibiotic Awareness Day 2013: 'Everyone is responsible' 18 November 2013NewsCorporate EMA promotes consistent development of bioequivalence studies through product-specific guidance 15 November 2013NewsHuman Mitigating risk aversion in medicines regulation in the interest of public health 15 November 2013NewsCorporate EMA provides guidance on development of medicines to prevent stroke in patients with atrial fibrillation – comments invited 15 November 2013NewsHuman World Diabetes Day – more treatment options to meet needs of growing patient numbers 14 November 2013NewsHuman 1 … 212 213 214 215 216 Page 216 of 384 217 218 219 220 … 384
European Medicines Agency recommends extending use of Abraxane to include treatment of pancreatic cancer 22 November 2013Press releaseHumanMedicines
European Medicines Agency's Committee on Herbal Medicinal Products elects new chair and vice-chair 20 November 2013NewsHerbalMedicines
European Medicines Agency finalises review of medicines concerned by Roche pharmacovigilance inspection 19 November 2013Press releaseCorporateMedicines
European Medicines Agency and EUnetHTA agree joint work plan 19 November 2013Press releaseCorporateMedicines
Regulatory information - EMA encourages companies to submit quality type-I variations for 2013 by end of November 18 November 2013NewsCorporate
EMA promotes consistent development of bioequivalence studies through product-specific guidance 15 November 2013NewsHuman
Mitigating risk aversion in medicines regulation in the interest of public health 15 November 2013NewsCorporate
EMA provides guidance on development of medicines to prevent stroke in patients with atrial fibrillation – comments invited 15 November 2013NewsHuman
World Diabetes Day – more treatment options to meet needs of growing patient numbers 14 November 2013NewsHuman